Search

Your search keyword '"LLeonart ME"' showing total 84 results

Search Constraints

Start Over You searched for: Author "LLeonart ME" Remove constraint Author: "LLeonart ME"
84 results on '"LLeonart ME"'

Search Results

1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

2. Tumor heterogeneity: Morphological, molecular and clinical implications

3. Tumor Profiling at the Service of Cancer Therapy

4. Editorial: Sphingolipid metabolism and cancer

5. The Role of Sphingolipids Metabolism in Cancer Drug Resistance

6. SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation

7. Targeting Sphingolipids for Cancer Therapy

8. Characterization of genetically modified mice for phosphoglycerate mutase, a vitally-essential enzyme in glycolysis

9. Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?

10. Tumor Profiling at the Service of Cancer Therapy

11. Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals

12. Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies

13. TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance

14. Editorial: Reciprocal crosstalk between the tumor microenvironment and cancer stem cells.

15. Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma.

16. Editorial: Sphingolipid metabolism and cancer.

17. Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy.

19. RNA-binding proteins: Underestimated contributors in tumorigenesis.

20. TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance.

21. Targeting Sphingolipids for Cancer Therapy.

22. SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation.

23. Characterization of genetically modified mice for phosphoglycerate mutase, a vitally-essential enzyme in glycolysis.

24. Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels.

25. Tumor Profiling at the Service of Cancer Therapy.

26. Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals.

27. Autophagy Takes Center Stage as a Possible Cancer Hallmark.

28. Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis.

29. Insights into new mechanisms and models of cancer stem cell multidrug resistance.

30. Autophagy inhibition as a promising therapeutic target for laryngeal cancer.

31. Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer.

32. Expression patterns and bioinformatic analysis of miR-1260a and miR-1274a in Prostate Cancer Tunisian patients.

33. Otologic, audiometric and speech findings in patients undergoing surgery for cleft palate.

34. Reactive Oxygen Species-Mediated Autophagy Defines the Fate of Cancer Stem Cells.

35. The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapy.

36. Mitochondrial dysfunction and potential anticancer therapy.

37. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.

38. DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders.

39. Absence of Relationship between Mitochondrial DNA Haplogroups and Cisplatin-Induced Hearing Loss.

40. Targeting cancer cells through antibiotics-induced mitochondrial dysfunction requires autophagy inhibition.

41. Impaired mitophagy in Fanconi anemia is dependent on mitochondrial fission.

42. The cancer stem-cell signaling network and resistance to therapy.

43. Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy.

44. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

45. Disruptive chemicals, senescence and immortality.

46. Dysregulated glycolysis as an oncogenic event.

47. Disruption of the ribosomal P complex leads to stress-induced autophagy.

48. RPLP1, a crucial ribosomal protein for embryonic development of the nervous system.

49. Schwannomas, benign tumors with a senescent phenotype.

50. Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2.

Catalog

Books, media, physical & digital resources